Dynamics of changes in plasma fatty acid binding proteins and intestinal zonulin in patients with generalized intra-abdominal infection and abdominal sepsis depending on the severity of patients

Keywords: generalized intra-abdominal infection, abdominal sepsis, biomarkers, I-FABP, zonulin, results.

Abstract

Objective. Determine the levels of plasma intestinal fatty acid binding proteins levels in combination with zonulin in patients with generalized intra-abdominal infection and abdominal sepsis, and define the clinical usefulness them to assess the severity of patients.

Materials ad methods. This study was based on an analysis of 59 patients of both sexes aged 18 to 70 years with generalized intra-abdominal infection (gIAI) and abdominal sepsis (AS).

Results. According to the aims and objectives of the study the patients were divided into three groups: the 1st group - 26 patients with generalized peritonitis without sepsis according to the «Sepsis-3» criterion; the 2nd group - 24 patients with sepsis, and the 3rd group - 9 patients with septic shock. We found statistically significant higher levels of I-FABP in the all groups of patients (P = 0.000). The same tendency was observed in all periods of the study, and the most significant levels of I-FABP were by the tenth day after surgery in patients with septic shock: IQR 1567.3- 3876.1 (P = 0.000). Patients with abdominal sepsis did not have a statistically significant change in zonulin levels compared to patients with gIAI without sepsis (P = 0.560) and a similar trend was observed on the 3rd day after surgery (P = 0.135). Only by the 7th and 10th days after surgery changes in zonulin levels were significant in intra-abdominal infection patients without sepsis, with abdominal sepsis and septic shock (P = 0.000 and P = 0.004, respectively).

Conclusions. Serum I-FABP levels were valuable and objectively early predictors of the severity of gastrointestinal injuries in gIAI. We also presented evidence of increased plasma zonulin levels in generalized intra-abdominal infection compared with the control group. Elevated zonulin levels were an additional indicator of the observed increase in intestinal permeability during gIAI, but zonulin was not an early biomarker of the severity of gastrointestinal damage like I-FABP.

Author Biographies

I. A. Kryvoruchko, Kharkiv National Medical University

Kryvoruchko Igor Andriiovych – MD, DSci(Med), Professor,
Head of the Surgery Department No. 2,
Kharkiv National Medical University,
4 Nauki ave., 61022, Kharkiv, Ukraine
ikryvoruchko60@gmail.com
https://orcid.org/0000-0002-5525-701Х.

M. O. Sykal, Kharkiv National Medical University

Sykal Mykola Olexandrovich – PhD(Med), assistant professor
Department of Surgery No.2
Kharkiv National Medical University,
4 Nauki ave., 61022, Kharkiv, Ukraine
https://orcid.org/0000-0002-2082-7449

References

Labelle A, Juang P, Reichley R, Micek S, Hoffmann J, Hoban A, et al. The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*. Crit Care Med. 2012 Jul;40(7):2016-21. doi: 10.1097/CCM.0b013e318250aa72. PMID: 22584765.

Reintam A, Parm P, Kitus R, Kern H, Starkopf J. Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand. 2009 Mar;53(3):318-24. doi: 10.1111/j.1399-6576.2008.01860.x. PMID: 19243317.

Leaphart CL, Tepas JJ 3rd. The gut is a motor of organ system dysfunction. Surgery. 2007 May;141(5):563-9. doi: 10.1016/j.surg.2007.01.021. PMID: 17462455.

Fink MP. Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care. 2003 Apr;9(2):143-51. doi: 10.1097/00075198-200304000-00011. PMID: 12657978.

Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock. 2007 Oct;28(4):384-93. doi: 10.1097/shk.0b013e31805569df. PMID: 17577136; PMCID: PMC2084394.

Piton G, Belon F, Cypriani B, Regnard J, Puyraveau M, Manzon C, et al. Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality. Crit Care Med. 2013 Sep;41(9):2169-76. doi: 10.1097/CCM.0b013e31828c26b5. PMID: 23782971.

Reintam A, Parm P, Kitus R, Starkopf J, Kern H. Gastrointestinal failure score in critically ill patients: a prospective observational study. Crit Care. 2008;12(4):R90. doi: 10.1186/cc6958. Epub 2008 Jul 14. Erratum in: Crit Care. 2008;12(6):435. PMID: 18625051; PMCID: PMC2575570.

Reintam A, Parm P, Redlich U, Tooding LM, Starkopf J, Köhler F, et al. Gastrointestinal failure in intensive care: a retrospective clinical study in three different intensive care units in Germany and Estonia. BMC Gastroenterol. 2006 Jun 22;6:19. doi: 10.1186/1471-230X-6-19. PMID: 16792799; PMCID: PMC1513588.

Reintam Blaser A, Malbrain ML, Starkopf J, Fruhwald S, Jakob SM, et al. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med. 2012 Mar;38(3):384-94. doi: 10.1007/s00134-011-2459-y. Epub 2012 Feb 7. PMID: 22310869; PMCID: PMC3286505.

Schroeder F, Jolly CA, Cho TH, Frolov A. Fatty acid binding protein isoforms: structure and function. Chem Phys Lipids. 1998 Mar;92(1):1-25. doi: 10.1016/s0009-3084(98)00003-6. PMID: 9631535.

Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005 Feb;352(1-2):15-35. doi: 10.1016/j.cccn.2004.09.001. PMID: 15653098.

Li H, Chen Y, Huo F, Wang Y, Zhang D. Association between acute gastrointestinal injury and biomarkers of intestinal barrier function in critically ill patients. BMC Gastroenterol. 2017 Mar 29;17(1):45. doi: 10.1186/s12876-017-0603-z. PMID: 28356059; PMCID: PMC5372314.

Otani S, Coopersmith CM. Gut integrity in critical illness. J Intensive Care. 2019 Mar 20;7:17. doi: 10.1186/s40560-019-0372-6. PMID: 30923621; PMCID: PMC6425574.

Tsukita S, Furuse M. The structure and function of claudins, cell adhesion molecules at tight junctions. Ann N Y Acad Sci. 2000;915:129-35. doi: 10.1111/j.1749-6632.2000.tb05235.x. PMID: 11193568.

Tajik N, Frech M, Schulz O, Schälter F, Lucas S, Azizov V, et al. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun. 2020 Apr 24;11(1):1995. doi: 10.1038/s41467-020-15831-7. PMID: 32332732; PMCID: PMC7181728.

Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000 Dec;113 Pt 24:4435-40. PMID: 11082037.

Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000 Apr 29;355(9214):1518-9. doi: 10.1016/S0140-6736(00)02169-3. PMID: 10801176.

Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernández-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One. 2012;7(5):e37160. doi: 10.1371/journal.pone.0037160. Epub 2012 May 18. PMID: 22629362; PMCID: PMC3356365.

Fasano A. Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci. 2012 Jul;1258(1):25-33. doi: 10.1111/j.1749-6632.2012.06538.x. PMID: 22731712; PMCID: PMC3384703.

Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006 May;55(5):1443-9. doi: 10.2337/db05-1593. PMID: 16644703.

Smecuol E, Sugai E, Niveloni S, Vázquez H, Pedreira S, Mazure R, et al. Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin Gastroenterol Hepatol. 2005 Apr;3(4):335-41. doi: 10.1016/s1542-3565(04)00778-5. PMID: 15822038.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287. PMID: 26903338; PMCID: PMC4968574.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18. PMID: 28101605.

Claridge JA, Banerjee A, Kelly KB, Leukhardt WH, Carter JW, Haridas M, et al. Bacterial species-specific hospital mortality rate for intra-abdominal infections. Surg Infect (Larchmt). 2014 Jun;15(3):194-9. doi: 10.1089/sur.2011.039. Epub 2014 May 6. PMID: 24801801; PMCID: PMC4063368.

Reintam Blaser A, Starkopf J, Alhazzani W, Berger MM, Casaer MP, Deane AM, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med. 2017 Mar;43(3):380-398. doi: 10.1007/s00134-016-4665-0. Epub 2017 Feb 6. PMID: 28168570; PMCID: PMC5323492.

Nalle SC, Turner JR. Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease. Mucosal Immunol. 2015 Jul;8(4):720-30. doi: 10.1038/mi.2015.40. Epub 2015 May 6. PMID: 25943273.

Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, et al. Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol. 2014 Nov 18;14:189. doi: 10.1186/s12876-014-0189-7. PMID: 25407511; PMCID: PMC4253991.

Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer. 2005 Jan 1;103(1):191-9. doi: 10.1002/cncr.20733. PMID: 15573372.

Grootjans J, Thuijls G, Verdam F, Derikx JP, Lenaerts K, Buurman WA. Non-invasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg. 2010 Mar 27;2(3):61-9. doi: 10.4240/wjgs.v2.i3.61. PMID: 21160852; PMCID: PMC2999221.

Schurink M, Kooi EM, Hulzebos CV, Kox RG, Groen H, Heineman E, et al. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS One. 2015 Mar 20;10(3):e0121336. doi: 10.1371/journal.pone.0121336. PMID: 25793701; PMCID: PMC4368100.

Kitai T, Kim YH, Kiefer K, Morales R, Borowski AG, Grodin JL, Tang WHW. Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure. Clin Biochem. 2017 Jun;50(9):491-5. doi: 10.1016/j.clinbiochem.2017.02.014. Epub 2017 Feb 20. PMID: 28232029; PMCID: PMC5474350.

Kryvoruchko IA, Boyko VV, Honcharova NN, Taraban IA, Arsenyev OV, Ivanova YuV et al. Evaluation of intestinal barrier biomarker i-fabp and severity of patients in acute pancreatitis. Novosti Khirurgii. 2019;27(6):640-649. doi: doi: 10.18484/2305-0047.2019.6.640.

Aasbrenn M, Lydersen S, Farup PG. Changes in serum zonulin in individuals with morbid obesity after weight-loss interventions: a prospective cohort study. BMC Endocr Disord. 2020 Jul 22;20(1):108. doi: 10.1186/s12902-020-00594-5. PMID: 32698783; PMCID: PMC7374843.

Martinez EE, Zurakowski D, Pereira L, Freire R, Emans JB, Nurko S, et al. Interleukin-10 and Zonulin Are Associated With Postoperative Delayed Gastric Emptying in Critically Ill Surgical Pediatric Patients: A Prospective Pilot Study. JPEN J Parenter Enteral Nutr. 2020 Nov;44(8):1407-1416. doi: 10.1002/jpen.1874. Epub 2020 Jun 3. PMID: 32386238; PMCID: PMC7754495.

Ziakas PD, Voulgarelis M, Felekouras E, Anagnostou D, Tzelepis GE. Myelofibrosis-associated massive splenomegaly: a cause of increased intra-abdominal pressure, pulmonary hypertension, and positional dyspnea. Am J Hematol. 2005 Oct;80(2):128-32. doi: 10.1002/ajh.20388. PMID: 16184577.

Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am. 2001 Oct;81(5):1063-75, vi. doi: 10.1016/s0039-6109(05)70184-5. PMID: 11589245.

Sugerman HJ, DeMaria EJ, Felton WL 3rd, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology. 1997 Aug;49(2):507-11. doi: 10.1212/wnl.49.2.507. PMID: 9270586.

Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain ML, De Keulenaer B, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013 Jul;39(7):1190-206. doi: 10.1007/s00134-013-2906-z. Epub 2013 May 15. PMID: 23673399; PMCID: PMC3680657.

Published
2021-07-28
How to Cite
Kryvoruchko, I. A., & Sykal, M. O. (2021). Dynamics of changes in plasma fatty acid binding proteins and intestinal zonulin in patients with generalized intra-abdominal infection and abdominal sepsis depending on the severity of patients. Klinicheskaia Khirurgiia, 88(3-4), 46-53. https://doi.org/10.26779/2522-1396.2021.3-4.46
Section
General Problems of Surgery